IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 18571 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Logistics management provides greater efficiency, governance and compliance
Francesco Ferrara,Priscilla Santilli,Antonio Vitiello,Giampiero Forte,Vilma D’Aiuto
International Journal of Clinical Pharmacy.2021;43(5)1431
[DOI]
2Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
Antonio Vitiello,Francesco Ferrara
Current Research in Pharmacology and Drug Discovery.2021;2(5)100056
[DOI]
3Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
Antonio Vitiello,Francesco Ferrara
Respiratory Medicine.2021;178(5)106322
[DOI]
4Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade
A. Vitiello,R. La Porta,V. D'Aiuto,F. Ferrara
Human Immunology.2021;82(4)264
[DOI]
5The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced
Antonio Vitiello,Raffaele La Porta,Vilma D’Aiuto,Francesco Ferrara
Egyptian Liver Journal.2021;11(1)264
[DOI]
6Efficacy of synthetic glucocorticoids in COVID-19 endothelites
Francesco Ferrara,Antonio Vitiello
Naunyn-Schmiedeberg's Archives of Pharmacology.2021;394(5)1003
[DOI]
7Plausible Positive Effects of Statins in COVID-19 Patient
Antonio Vitiello,Francesco Ferrara
Cardiovascular Toxicology.2021;21(10)781
[DOI]
8The advantages of drug treatment with statins in patients with SARS-CoV-2 infection
Francesco Ferrara,Antonio Vitiello
Wiener klinische Wochenschrift.2021;133(17-18)958
[DOI]
9Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients
Antonio Vitiello,Francesco Ferrara
Wiener klinische Wochenschrift.2021;133(17-18)983
[DOI]
10Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection
Antonio Vitiello,Francesco Ferrara
Molecular Biology Reports.2021;133(17-18)983
[DOI]
11Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection
Antonio Vitiello,Francesco Ferrara
Naunyn-Schmiedeberg's Archives of Pharmacology.2021;133(17-18)983
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow